Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WSAVA reports no new evidence of COVID-19 transmission from pets to humans
Although more pets will undoubtedly test positive over time, Dr Michael Lappin reminded veterinary professionals that numbers overall remain very small.

Vets urged to encourage owners not to relinquish infected animals

Speakers at a WSAVA webinar, held on September 15 2020, have appealed for kindness towards companion animals testing positive for SARS-Cov-2 and stressed that there is still no evidence of transmission from a companion animal to a human.

During the webinar, Dr Michael Lappin, chair of the WSAVA’s One Health Committee, confirmed that the virus is a reverse zoonoses, with humans passing SARS-Cov-2 to pets in the few cases that have been reported worldwide.

Dr Lappin went on to explain that experimental studies at Colorado State University have shown that both cats and dogs have demonstrated a ‘robust antibody response’, and typically display no symptoms. While dogs do not shed live virus, cats shed the virus for a short period of time and could transmit the disease to other cats.

According to Dr Lappin, further data is being collected to explore whether the clinical illness in naturally infected dogs or cats is common or important. He added that it is currently unclear whether these animals require specific treatment.

Speaking on the topic of preventative health, Dr Richard Squires, chair of the WSAVA’s Vaccination Guidelines group, reminded veterinary professionals of the importance of risk-benefit analyses during the pandemic. He suggested that the current priority should be the protection of puppies and kittens using core vaccines, with the last or sole dose being given no earlier than 16 weeks.

More advice for veterinary professionals on vaccination during the pandemic is available on WSAVA’s Resource Hub.

Commenting on the webinar, Dr Lappin said: “The other panelists and I hope that the content of the webinar can be used to improve the welfare and health of companion animals.  We all look forward to working together to provide additional updates to the WSAVA membership as new information comes available.”

The full webinar can be viewed by clicking here.

Image (c) WSAVA.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk